IBDEI055 ; ; 06-AUG-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;AUG 06, 2013
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,6612,1,4,0)
 ;;=4^743.51
 ;;^UTILITY(U,$J,358.3,6612,2)
 ;;=^272828
 ;;^UTILITY(U,$J,358.3,6613,0)
 ;;=743.59^^51^452^70
 ;;^UTILITY(U,$J,358.3,6613,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6613,1,3,0)
 ;;=3^Posterior Seg Anomaly Congenital
 ;;^UTILITY(U,$J,358.3,6613,1,4,0)
 ;;=4^743.59
 ;;^UTILITY(U,$J,358.3,6613,2)
 ;;=^272839
 ;;^UTILITY(U,$J,358.3,6614,0)
 ;;=757.33^^51^452^23
 ;;^UTILITY(U,$J,358.3,6614,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6614,1,3,0)
 ;;=3^Cong Pigment Anom of Skin
 ;;^UTILITY(U,$J,358.3,6614,1,4,0)
 ;;=4^757.33
 ;;^UTILITY(U,$J,358.3,6614,2)
 ;;=^27472
 ;;^UTILITY(U,$J,358.3,6615,0)
 ;;=909.2^^51^452^48
 ;;^UTILITY(U,$J,358.3,6615,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6615,1,3,0)
 ;;=3^Late Effect of Radiation Retinopathy
 ;;^UTILITY(U,$J,358.3,6615,1,4,0)
 ;;=4^909.2
 ;;^UTILITY(U,$J,358.3,6615,2)
 ;;=^275257
 ;;^UTILITY(U,$J,358.3,6616,0)
 ;;=377.41^^51^453^91
 ;;^UTILITY(U,$J,358.3,6616,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6616,1,3,0)
 ;;=3^Optic Neuropathy, Ischemic
 ;;^UTILITY(U,$J,358.3,6616,1,4,0)
 ;;=4^377.41
 ;;^UTILITY(U,$J,358.3,6616,2)
 ;;=Optic Neuropathy, Ischemic^269231
 ;;^UTILITY(U,$J,358.3,6617,0)
 ;;=377.21^^51^453^33
 ;;^UTILITY(U,$J,358.3,6617,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6617,1,3,0)
 ;;=3^Drusen (ONH)
 ;;^UTILITY(U,$J,358.3,6617,1,4,0)
 ;;=4^377.21
 ;;^UTILITY(U,$J,358.3,6617,2)
 ;;=^269221
 ;;^UTILITY(U,$J,358.3,6618,0)
 ;;=377.10^^51^453^79
 ;;^UTILITY(U,$J,358.3,6618,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6618,1,3,0)
 ;;=3^Optic Atrophy
 ;;^UTILITY(U,$J,358.3,6618,1,4,0)
 ;;=4^377.10
 ;;^UTILITY(U,$J,358.3,6618,2)
 ;;=^85926
 ;;^UTILITY(U,$J,358.3,6619,0)
 ;;=377.30^^51^453^90
 ;;^UTILITY(U,$J,358.3,6619,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6619,1,3,0)
 ;;=3^Optic Neuritis,Unspec
 ;;^UTILITY(U,$J,358.3,6619,1,4,0)
 ;;=4^377.30
 ;;^UTILITY(U,$J,358.3,6619,2)
 ;;=^86002
 ;;^UTILITY(U,$J,358.3,6620,0)
 ;;=377.01^^51^453^96
 ;;^UTILITY(U,$J,358.3,6620,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6620,1,3,0)
 ;;=3^Papilledema
 ;;^UTILITY(U,$J,358.3,6620,1,4,0)
 ;;=4^377.01
 ;;^UTILITY(U,$J,358.3,6620,2)
 ;;=Papilledema Associated with Increased Intracranial Pressure^269212
 ;;^UTILITY(U,$J,358.3,6621,0)
 ;;=379.40^^51^453^107
 ;;^UTILITY(U,$J,358.3,6621,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6621,1,3,0)
 ;;=3^Pupil, Abnormal Function
 ;;^UTILITY(U,$J,358.3,6621,1,4,0)
 ;;=4^379.40
 ;;^UTILITY(U,$J,358.3,6621,2)
 ;;=Pupil, Abnormal Function^101288
 ;;^UTILITY(U,$J,358.3,6622,0)
 ;;=362.34^^51^453^6
 ;;^UTILITY(U,$J,358.3,6622,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6622,1,3,0)
 ;;=3^Amaurosis Fugax
 ;;^UTILITY(U,$J,358.3,6622,1,4,0)
 ;;=4^362.34
 ;;^UTILITY(U,$J,358.3,6622,2)
 ;;=Amaurosis Fugax^268622
 ;;^UTILITY(U,$J,358.3,6623,0)
 ;;=351.0^^51^453^12
 ;;^UTILITY(U,$J,358.3,6623,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6623,1,3,0)
 ;;=3^Bell's Palsy
 ;;^UTILITY(U,$J,358.3,6623,1,4,0)
 ;;=4^351.0
 ;;^UTILITY(U,$J,358.3,6623,2)
 ;;=Bell's Palsy^13238
 ;;^UTILITY(U,$J,358.3,6624,0)
 ;;=333.81^^51^453^13
 ;;^UTILITY(U,$J,358.3,6624,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6624,1,3,0)
 ;;=3^Blepharospasm
 ;;^UTILITY(U,$J,358.3,6624,1,4,0)
 ;;=4^333.81
 ;;^UTILITY(U,$J,358.3,6624,2)
 ;;=Blepharospasm^15293
 ;;^UTILITY(U,$J,358.3,6625,0)
 ;;=437.9^^51^453^21
 ;;^UTILITY(U,$J,358.3,6625,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6625,1,3,0)
 ;;=3^Cerebrovascular Dis
 ;;^UTILITY(U,$J,358.3,6625,1,4,0)
 ;;=4^437.9
 ;;^UTILITY(U,$J,358.3,6625,2)
 ;;=Cerebrovascular Dis^21803
 ;;^UTILITY(U,$J,358.3,6626,0)
 ;;=368.2^^51^453^29
 ;;^UTILITY(U,$J,358.3,6626,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6626,1,3,0)
 ;;=3^Diplopia
 ;;^UTILITY(U,$J,358.3,6626,1,4,0)
 ;;=4^368.2
 ;;^UTILITY(U,$J,358.3,6626,2)
 ;;=Diplopia^35208
 ;;^UTILITY(U,$J,358.3,6627,0)
 ;;=350.9^^51^453^38
 ;;^UTILITY(U,$J,358.3,6627,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6627,1,3,0)
 ;;=3^Fifth Nerve Paresis
 ;;^UTILITY(U,$J,358.3,6627,1,4,0)
 ;;=4^350.9
 ;;^UTILITY(U,$J,358.3,6627,2)
 ;;=Fifth Nerve Palsy^265329
 ;;^UTILITY(U,$J,358.3,6628,0)
 ;;=379.50^^51^453^72
 ;;^UTILITY(U,$J,358.3,6628,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6628,1,3,0)
 ;;=3^Nystagmus,Unspec
 ;;^UTILITY(U,$J,358.3,6628,1,4,0)
 ;;=4^379.50
 ;;^UTILITY(U,$J,358.3,6628,2)
 ;;=Nystagmus^84761
 ;;^UTILITY(U,$J,358.3,6629,0)
 ;;=802.6^^51^453^95
 ;;^UTILITY(U,$J,358.3,6629,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6629,1,3,0)
 ;;=3^Orbital Floor Fracture
 ;;^UTILITY(U,$J,358.3,6629,1,4,0)
 ;;=4^802.6
 ;;^UTILITY(U,$J,358.3,6629,2)
 ;;=Orbital Floor Fracture^273684
 ;;^UTILITY(U,$J,358.3,6630,0)
 ;;=192.0^^51^453^26
 ;;^UTILITY(U,$J,358.3,6630,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6630,1,3,0)
 ;;=3^Cranial Nerve Neopl,Malignant
 ;;^UTILITY(U,$J,358.3,6630,1,4,0)
 ;;=4^192.0
 ;;^UTILITY(U,$J,358.3,6630,2)
 ;;=Mal Neoplasm, Cranial Nerve^267290
 ;;^UTILITY(U,$J,358.3,6631,0)
 ;;=225.1^^51^453^20
 ;;^UTILITY(U,$J,358.3,6631,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6631,1,3,0)
 ;;=3^Cerebral Nerve Neopl,Benign
 ;;^UTILITY(U,$J,358.3,6631,1,4,0)
 ;;=4^225.1
 ;;^UTILITY(U,$J,358.3,6631,2)
 ;;=Benign Neoplasm Cranial Nerve^13298
 ;;^UTILITY(U,$J,358.3,6632,0)
 ;;=346.90^^51^453^47
 ;;^UTILITY(U,$J,358.3,6632,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6632,1,3,0)
 ;;=3^Headache,Migraine
 ;;^UTILITY(U,$J,358.3,6632,1,4,0)
 ;;=4^346.90
 ;;^UTILITY(U,$J,358.3,6632,2)
 ;;=Headache, Migraine^293880
 ;;^UTILITY(U,$J,358.3,6633,0)
 ;;=784.0^^51^453^46
 ;;^UTILITY(U,$J,358.3,6633,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6633,1,3,0)
 ;;=3^Headache
 ;;^UTILITY(U,$J,358.3,6633,1,4,0)
 ;;=4^784.0
 ;;^UTILITY(U,$J,358.3,6633,2)
 ;;=Headache^54133
 ;;^UTILITY(U,$J,358.3,6634,0)
 ;;=V41.0^^51^453^105
 ;;^UTILITY(U,$J,358.3,6634,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6634,1,3,0)
 ;;=3^Problems with Sight
 ;;^UTILITY(U,$J,358.3,6634,1,4,0)
 ;;=4^V41.0
 ;;^UTILITY(U,$J,358.3,6634,2)
 ;;=Problem with sight^295427
 ;;^UTILITY(U,$J,358.3,6635,0)
 ;;=348.2^^51^453^56
 ;;^UTILITY(U,$J,358.3,6635,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6635,1,3,0)
 ;;=3^Intracranial Hypertension
 ;;^UTILITY(U,$J,358.3,6635,1,4,0)
 ;;=4^348.2
 ;;^UTILITY(U,$J,358.3,6635,2)
 ;;=Intracranial Hypertension^100293
 ;;^UTILITY(U,$J,358.3,6636,0)
 ;;=378.50^^51^453^78
 ;;^UTILITY(U,$J,358.3,6636,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6636,1,3,0)
 ;;=3^Ophthalmoplegia,Unspec
 ;;^UTILITY(U,$J,358.3,6636,1,4,0)
 ;;=4^378.50
 ;;^UTILITY(U,$J,358.3,6636,2)
 ;;=Opthalmoplegia, Unspec^265442
 ;;^UTILITY(U,$J,358.3,6637,0)
 ;;=351.8^^51^453^49
 ;;^UTILITY(U,$J,358.3,6637,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6637,1,3,0)
 ;;=3^Hemifacial Spasm
 ;;^UTILITY(U,$J,358.3,6637,1,4,0)
 ;;=4^351.8
 ;;^UTILITY(U,$J,358.3,6637,2)
 ;;=Hemifacial Spasm^87589
 ;;^UTILITY(U,$J,358.3,6638,0)
 ;;=446.5^^51^453^121
 ;;^UTILITY(U,$J,358.3,6638,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6638,1,3,0)
 ;;=3^Temporal Arteritis
 ;;^UTILITY(U,$J,358.3,6638,1,4,0)
 ;;=4^446.5
 ;;^UTILITY(U,$J,358.3,6638,2)
 ;;=Giant Cell Arteritis^117658
 ;;^UTILITY(U,$J,358.3,6639,0)
 ;;=378.73^^51^453^75
 ;;^UTILITY(U,$J,358.3,6639,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6639,1,3,0)
 ;;=3^Ocular Myasthenia Gravis
 ;;^UTILITY(U,$J,358.3,6639,1,4,0)
 ;;=4^378.73
 ;;^UTILITY(U,$J,358.3,6639,2)
 ;;=Ocular Myasthenia Gravis^269274
 ;;^UTILITY(U,$J,358.3,6640,0)
 ;;=377.24^^51^453^106
 ;;^UTILITY(U,$J,358.3,6640,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6640,1,3,0)
 ;;=3^Pseudopapilledema
 ;;^UTILITY(U,$J,358.3,6640,1,4,0)
 ;;=4^377.24
 ;;^UTILITY(U,$J,358.3,6640,2)
 ;;=Pseudopapilledema^269224
 ;;^UTILITY(U,$J,358.3,6641,0)
 ;;=781.0^^51^453^3
 ;;^UTILITY(U,$J,358.3,6641,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6641,1,3,0)
 ;;=3^Abnormal Involuntary Movements
 ;;^UTILITY(U,$J,358.3,6641,1,4,0)
 ;;=4^781.0
 ;;^UTILITY(U,$J,358.3,6641,2)
 ;;=Lid Myokymia^23827
 ;;^UTILITY(U,$J,358.3,6642,0)
 ;;=088.81^^51^453^57
 ;;^UTILITY(U,$J,358.3,6642,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6642,1,3,0)
 ;;=3^Lyme Anthropoed Borne Disease
 ;;^UTILITY(U,$J,358.3,6642,1,4,0)
 ;;=4^088.81
 ;;^UTILITY(U,$J,358.3,6642,2)
 ;;=^72315
 ;;^UTILITY(U,$J,358.3,6643,0)
 ;;=227.3^^51^453^103
 ;;^UTILITY(U,$J,358.3,6643,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6643,1,3,0)
 ;;=3^Pituitary/Craniopharyngeal Neopl,Benign
 ;;^UTILITY(U,$J,358.3,6643,1,4,0)
 ;;=4^227.3
 ;;^UTILITY(U,$J,358.3,6643,2)
 ;;=^267690
 ;;^UTILITY(U,$J,358.3,6644,0)
 ;;=237.0^^51^453^104
 ;;^UTILITY(U,$J,358.3,6644,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6644,1,3,0)
 ;;=3^Pituitary/Craniopharyngeal Neopl,Uncert
 ;;^UTILITY(U,$J,358.3,6644,1,4,0)
 ;;=4^237.0
 ;;^UTILITY(U,$J,358.3,6644,2)
 ;;=^81969
 ;;^UTILITY(U,$J,358.3,6645,0)
 ;;=250.52^^51^453^27
 ;;^UTILITY(U,$J,358.3,6645,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6645,1,3,0)
 ;;=3^DM II w/Ophthalmic,Uncontrolled
 ;;^UTILITY(U,$J,358.3,6645,1,4,0)
 ;;=4^250.52
 ;;^UTILITY(U,$J,358.3,6645,2)
 ;;=^331801
 ;;^UTILITY(U,$J,358.3,6646,0)
 ;;=253.8^^51^453^35
 ;;^UTILITY(U,$J,358.3,6646,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6646,1,3,0)
 ;;=3^Empty Sella/Turcica
 ;;^UTILITY(U,$J,358.3,6646,1,4,0)
 ;;=4^253.8
 ;;^UTILITY(U,$J,358.3,6646,2)
 ;;=^87533
 ;;^UTILITY(U,$J,358.3,6647,0)
 ;;=300.11^^51^453^55
 ;;^UTILITY(U,$J,358.3,6647,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6647,1,3,0)
 ;;=3^Hysterical Blindness
 ;;^UTILITY(U,$J,358.3,6647,1,4,0)
 ;;=4^300.11
 ;;^UTILITY(U,$J,358.3,6647,2)
 ;;=^28139
 ;;^UTILITY(U,$J,358.3,6648,0)
 ;;=307.81^^51^453^48
 ;;^UTILITY(U,$J,358.3,6648,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6648,1,3,0)
 ;;=3^Headache,Tension
 ;;^UTILITY(U,$J,358.3,6648,1,4,0)
 ;;=4^307.81
 ;;^UTILITY(U,$J,358.3,6648,2)
 ;;=^100405
